TickerFactsScreenerDevelopers

RELMADA THERAPEUTICS, INC. (RLMD) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $8.9K2015: $23.3K2016: $562.3K2017: $49.7K2018: $12.4K2019: $84.85M2020: $182.05M$182.05M
2013Capital Expenditures (USD)2020
Fiscal YearCapital ExpendituresChange YoY
2020$182.05M+114.6%
2019$84.85M+684664.7%
2018$12.4K-75.1%
2017$49.7K-91.2%
2016$562.3K+2310.4%
2015$23.3K—
2013$8.9K—